Poster Sessions

Posters from ALL disciplines are welcome! 

2018 Session Dates

Graduate, Medical, PharmD Students
Tuesday, April 17
1:30-3:30 pm

Postdoctoral Fellows, Faculty and Staff
Wednesday, April 18
1:30-3:30 pm 


General Information

All poster sessions will be located in the Medical Education Research Facility (MERF) Atrium. For Health Sciences Research Week poster sessions, posters must be posted by 1:30 pm and cannot be taken down before 3:30 pm. Presenters must be available to answer questions during their assigned time. Judges are not required to wait for a missing presenter but most will considerately check back a few times before giving a poster a "no score". Poster numbers will be emailed to presenters by Friday, April 6. Pushpins will also be available in the MERF Atrium as needed.


Deadlines

The poster registration deadline is Monday, March 26 at 5:00 pm.


Awards

  • The Carver College of Medicine will award three awards of $350 at each poster session.

     
  • The College of Pharmacy will award two awards of $350 at each poster session.

     
  • The Institute for Clinical and Translational Science will award two awards of $350 at each poster session.

     
  • The VA Health System will award three professional development awards of $350. 

Judging Criteria

The abstract will be judged in conjunction with the poster. The individual presenting the poster must be present during the entire session. Odd-numbered posters will be judged 1:30-2:30 and even-numbered posters 2:30-3:30. There is a 250-word limit, excluding the title and authors. Submissions for judging by the Institute for Clinical and Translational Science will need to include an explanation of how the entry fits into one of four areas of translational science listed below.  Submissions for judging by the Iowa City VA Medical Center will need to include an explanation of how the entry applies to veterans.  Please note, faculty posters are not judged. 

  • T1 translational research (i.e., translation to humans) involves the testing of findings from basic research for clinical effect and/or applicability in humans and is exemplified by preclinical studies, animal models of human disease, and first-in-human studies (i.e., healthy volunteers; proof of concept studies; and Phase 1 clinical trials).

     
  • T2 translational research (i.e., translation to patients) involves the testing of new treatments and interventions under controlled environments to form the basis for clinical application and evidence-based guidelines and exemplified by Phase 2 and Phase 3 clinical trials, and uncontrolled observational studies or case series.

     
  • T3 translational research (i.e., translation to medical practice) involves the application of recommendations or guidelines in the medical practices which patients typically frequent to yield knowledge about how interventions work in real-world settings and is exemplified by: Phase 4 clinical trials, dissemination, implementation, and communications studies; and clinical outcomes and comparative effectiveness research.

     
  • T4 translational research (i.e., translation to populations) involves the development of new health policies to benefit populations; is based on successful T1, T2, and T3 studies; and is exemplified by population-level outcomes studies and studies of social determinants of health.

Board Specifications

Poster boards have a display area of approximately 4'x6'. Presenters are reminded that, in order to preserve the condition of display boards for future use, they are discouraged from tacking posters to the frame surrounding the display area with tacks or adhesive that haven't been pre-approved by the event staff.